January 17, 2017 ReSeqTB Data Platform Now Available to Public January 17, 2017 TUCSON, Ariz., January 17, 2017 —The Rapid Drug Susceptibility Testing Consortium, coordinated by
January 12, 2017 A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis
January 12, 2017 Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
January 12, 2017 Emerging Good Practices for Translatability Assessment (TA) of Patient-Reported Outcome (PRO) Measures
January 5, 2017 Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
January 3, 2017 Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action